This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Obamacare Is Healthy For This Investment Portfolio

By Covestor


Healthcare stocks are outperforming this year and a portfolio manager who uses a sector-rotation strategy thinks the industry still has to room to run on Obamacare and positive fundamentals.

Despite well-publicized problems over the rollout of the federal health insurance exchange website, "the fact remains it's happening for now and likely will not change," says Alex Gurvich, co-founder and managing partner of the Rockledge Group, which manages the L2 Portfolio Covestor. "Obamacare is here to stay and it will drive up revenue and the bottom lines of healthcare companies because spending is going up."

The L2 Portfolio employs a sector-rotation approach to potentially outperform the S&P 500 over multi-year time frames. The underlying investments are typically sector-based ETFs.

The strategy currently has a position in Health Care Select Sector SPDR (NYSE: XLV). The ETF's tracking index top five holdings are Johnson & Johnson (NYSE: JNJ), Pfizer (NYSE: PFE), Merck (NYSE: MRK), Gilead (NASDAQ: GILD) and Bristol Myers Squibb (NYSE: BMY).

Aside from the tailwinds from Obamacare, Rockledge Group thinks the healthcare sector is undervalued and attractive from a fundamental perspective.

"Healthcare is traditionally considered a defensive sector because we still need to spend on healthcare even in a weak or uncertain economic environment," Gurvich said. "We are in a bull market yet this historically defensive industry is outperforming the S&P 500 this year."

Outside healthcare, the L2 Portfolio is also bullish on materials, industrials, consumer staples and consumer discretionary stocks. Rockledge Group seeks to identify outperforming sectors based on the economic cycle, fundamental research, technicals and other factors.

"We want to invest in the sectors that are best positioned in the current market environment and will outperform the lagging sectors we don't own," Gurvich says. "Different sectors perform differently during various phases of economic cycles."

Rather than investing in individual companies, Rockledge usually buys entire sectors with diversified ETFs in the L2 Portfolio.

"Most of the outperformance of a particular stock comes from the sector it is in. If a company is benefitting, then the entire sector is likely benefitting," Gurvich added.

He said the allocations in industrials and materials reflect the model's current preference for cyclical sectors.

"The U.S. economy is slowly on the mend," he said. "It may be two steps forward and one step back, but the overall slope is up. That's good for cyclical sectors like industrials and materials."

Finally, he said the dual positions in consumer staples and discretionary are somewhat of an anomaly because staples are considered a defensive sector, while discretionary stocks are generally a cyclical play.

"We view staples as undervalued according to our model," Gurvich said. Consumer staples are also in the portfolio as a defensive play because the model sees the market as a bit fragile after such a strong run for the S&P 500 so far in 2013, he noted.

Photo Credit: CarbonNYC

DISCLAIMER: The investments discussed are held in client accounts as of October 31, 2013. These investments may or may not be currently held in client accounts. The reader should not assume that any investments identified were or will be profitable or that any investment recommendations or investment decisions we make in the future will be profitable. Past performance is no guarantee of future results.

The Rockledge Group

The Rockledge Group

The Rockledge Group focuses on alternative strategies and sector investing. We focus on delivering positive risk-adjusted returns by forecasting the

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $95.03 -2.90%
FB $116.73 7.20%
GOOG $691.02 -2.10%
TSLA $247.54 -1.60%
YHOO $36.59 -0.97%


Chart of I:DJI
DOW 17,830.76 -210.79 -1.17%
S&P 500 2,075.81 -19.34 -0.92%
NASDAQ 4,805.2910 -57.85 -1.19%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs